federal_register: 2020-04990

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2020-04990 Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials Notice The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials." The meeting will be convened by Duke University's Robert J. Margolis, Center for Health Policy (Duke-Margolis) and supported by a cooperative agreement with FDA. The meeting is intended to gather industry, patient, clinician, researcher, institutional review board, ethicist, professional society and other stakeholder input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development. 2020-03-11 2020 3 https://www.federalregister.gov/documents/2020/03/11/2020-04990/scientific-and-ethical-considerations-for-the-inclusion-of-pregnant-women-in-clinical-trials https://www.govinfo.gov/content/pkg/FR-2020-03-11/pdf/2020-04990.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials." The meeting will be convened by Duke...  

Links from other tables